Filter Results :

Your search for Therapies returned 57 reports

Sort by


Vital Therapies Inc (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 Aug 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute li...

$ 250.00

Read More

Intra-Cellular Therapies Inc (ITCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Aug 2017  |  Published by:  GlobalData
SummaryIntra-Cellular Therapies Inc (ITI) is a biopharmaceutical company that discovers and develops novel drugs for the treatment of neuropsychiatric and neurologic disorders. The company's lead product candidate include ITI-007-lumateperone, which is intended for the treatment of schizophrenia, be...

$ 250.00

Read More

Diabetic Nephropathy Market (By Mode of Treatment: Drug Modifying Therapies, and Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

11 Aug 2017  |  Published by:  Variant Market Research
Global Diabetic Nephropathy Market is estimated to reach $3,826 million by 2024; growing at a CAGR of 5.9% from 2016 to 2024. Diabetic nephropathy involves damage of kidney due to the presence of diabetic mellitus. It is a progressive kidney disease majorly caused due to occurrence if persistent pro...

$ 4,995.00

Read More

Vital Therapies Inc (VTL) - Financial and Strategic SWOT Analysis Review

07 Aug 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute li...

$ 300.00

Read More

BioRestorative Therapies Inc (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Jul 2017  |  Published by:  GlobalData
SummaryBioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance, Inc. is a biotechnology company that develops products and therapies using cell and tissue protocols. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is design...

$ 250.00

Read More

Biotie Therapies Corp (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Jul 2017  |  Published by:  GlobalData
SummaryBiotie Therapies Corp (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as parkinson's disease, alzheimer's disease, pri...

$ 250.00

Read More

Vital Therapies Inc (VTL) - Medical Equipment - Deals and Alliances Profile

20 Jul 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute li...

$ 250.00

Read More

Advanced Inhalation Therapies (AIT) Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

20 Jul 2017  |  Published by:  GlobalData
SummaryAdvanced Inhalation Therapies (AIT) Ltd (AIT) focuses on the development and commercialization of nitric oxide (NO) based formulations for respiratory or infectious diseases. The company's pipeline product portfolio comprises NOxBR, NOxCF, NOxCOPD and NOxSYS. Its NOxBS is a proprietary delive...

$ 250.00

Read More

Advanced Catheter Therapies Inc - Medical Equipment - Deals and Alliances Profile

11 Jul 2017  |  Published by:  GlobalData
SummaryAdvanced Catheter Therapies Inc (ACT) is a medical device company that offers novel catheter technologies targeting vascular disease such as inflammation, thrombosis, occlusions and restenosis. The company is developing a device for restenosis and catheters for endovascular debulking. It offe...

$ 250.00

Read More

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

01 Jul 2017  |  Published by:  GBI Research
SummaryColorectal Cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. There were more than 1.4 million newly diagnosed CRC cases in 2012, accounting for 9.7% of the total number of cancer cases. This figure has been gradually rising in the Asia-Pacific ...

$ 4,995.00

Read More

CSU - Institute for Biologic Translational Therapies - Colorado Project Profile

28 Jun 2017  |  Published by:  Timetric
Synopsis"CSU - Institute for Biologic Translational Therapies - Colorado Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on cont...

$ 75.00

Read More

Natural Killer Cells Therapies- Competitive Landscape,Technology and Pipeline Analysis, 2017

01 Jun 2017  |  Published by:  DelveInsight
“Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell therapy products and NK cell augmenters in research and development.  The report covers 20+ companies, which are active in this field with 40+ products and...

$ 2,450.00

Read More

Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline

03 May 2017  |  Published by:  GBI Research
SummaryThe American Cancer Society (ACS) predicts that in 2017 there will be almost 173,000 new cases of leukemia, lymphoma and myeloma, with lymphomas the most prevalent. Due to a degree of crossover between hematological malignancies in terms of their underlying pathophysiology, it is not uncommon...

$ 6,995.00

Read More

Frontier Pharma: Alzheimer's Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression

01 May 2017  |  Published by:  GBI Research
SummaryAlzheimer’s disease (AD), the most common form of dementia, is a progressive, neurodegenerative and currently incurable disease characterized by loss of memory and other mental abilities. It has a devastating impact on independence and quality of life, with patients requiring full-time care i...

$ 6,995.00

Read More

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

01 Apr 2017  |  Published by:  GBI Research
SummaryRheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. It is characterized by synovial inflammation and gradual bone erosion over many years. Disease progression results in stiffness and pain, especially in the hands a...

$ 4,995.00

Read More
Total 57 records.